Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × High Risk Myeloid Malignancies × Transplantation Conditioning × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 2 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma 1 High Risk Myeloid Malignancies 1 Hematologic Neoplasms 1 Graft vs Host Disease 1

Interventions

Transplantation Conditioning 1 Thiotepa 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04990323 2025-02-25

US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies

ExCellThera inc.

Phase 1/2 Recruiting

High Risk Myeloid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡